NEPHROTRANS 840 mg enteric-coated capsules, 100 pcs

Instructions for use for NEPHROTRANS 840 mg enteric-coated capsules, 100 pcs

Summary: Nephrotrans 840 mg enteric-coated capsules contain the active substance sodium hydrogen carbonate. They are used for the treatment of metabolic hyperacidity of the blood (metabolic acidosis) and for maintenance treatment in chronic renal insufficiency. The dosage depends on the severity of the acidosis and is usually 4-6 capsules per day. Side effects may include flatulence, abdominal pain, kidney stones, allergic reactions and muscle cramps. The medicine must not be taken in case of hypersensitivity to the ingredients, base excess in the blood, low serum potassium or low-sodium diet. The duration of use should be agreed with a doctor and should not usually exceed 7-14 days.